A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer.
• The KIT oncogene plays a role in melanoma development and can be targeted by miR-221.
• Genetic mutations in regulatory elements can disrupt gene expression and disease risk.

Purpose of the Study:

• To investigate the role of genetic variants in the KIT oncogene's 3' UTR in melanoma risk.
• To determine if a specific KIT variant affects regulation by miR-221.
• To identify novel genetic markers for heritable melanoma risk.

Main Methods:

• Analysis of a genetic variant in the KIT 3' UTR.
• Reporter assays to assess the impact of the variant on miR-221 binding.
• Measurement of KIT mRNA and protein levels in patient samples.

Main Results:

• A KIT 3' UTR variant was identified, correlating with a >4-fold increased risk of acral melanoma.
• The variant creates a mismatch in the miR-221 binding site, leading to increased KIT oncogene expression.
• Elevated KIT mRNA and protein levels were observed in samples with the variant.

Conclusions:

• The identified KIT variant is a functional genetic marker associated with increased heritable risk of melanoma.
• Disruption of miRNA-mediated regulation of KIT contributes to melanoma pathogenesis.
• This variant serves as a potential biomarker for melanoma susceptibility.